CN1119291C - 医疗用电解水的制造方法及利用该水作透析液的透析装置 - Google Patents
医疗用电解水的制造方法及利用该水作透析液的透析装置 Download PDFInfo
- Publication number
- CN1119291C CN1119291C CN96108522A CN96108522A CN1119291C CN 1119291 C CN1119291 C CN 1119291C CN 96108522 A CN96108522 A CN 96108522A CN 96108522 A CN96108522 A CN 96108522A CN 1119291 C CN1119291 C CN 1119291C
- Authority
- CN
- China
- Prior art keywords
- water
- brine electrolysis
- mentioned
- negative electrode
- dialysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 134
- 238000000034 method Methods 0.000 title claims abstract description 14
- 238000000502 dialysis Methods 0.000 title claims description 45
- 239000007788 liquid Substances 0.000 title claims 2
- 238000004519 manufacturing process Methods 0.000 title description 6
- 210000004369 blood Anatomy 0.000 claims abstract description 25
- 239000008280 blood Substances 0.000 claims abstract description 25
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000011777 magnesium Substances 0.000 claims abstract description 4
- 239000011591 potassium Substances 0.000 claims abstract description 4
- 239000011734 sodium Substances 0.000 claims abstract description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910001424 calcium ion Inorganic materials 0.000 claims abstract description 3
- 238000005868 electrolysis reaction Methods 0.000 claims description 36
- 239000012267 brine Substances 0.000 claims description 27
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 27
- 238000001914 filtration Methods 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 8
- 230000004888 barrier function Effects 0.000 claims description 6
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims 4
- XZPVPNZTYPUODG-UHFFFAOYSA-M sodium;chloride;dihydrate Chemical compound O.O.[Na+].[Cl-] XZPVPNZTYPUODG-UHFFFAOYSA-M 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 229910001425 magnesium ion Inorganic materials 0.000 abstract 1
- 230000033116 oxidation-reduction process Effects 0.000 abstract 1
- 229910001414 potassium ion Inorganic materials 0.000 abstract 1
- 229910001415 sodium ion Inorganic materials 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 26
- 229910052760 oxygen Inorganic materials 0.000 description 26
- 239000001301 oxygen Substances 0.000 description 26
- 238000001223 reverse osmosis Methods 0.000 description 12
- 238000010586 diagram Methods 0.000 description 9
- 230000002070 germicidal effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000008151 electrolyte solution Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000001631 haemodialysis Methods 0.000 description 5
- 230000000322 hemodialysis Effects 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 238000009298 carbon filtering Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical class ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010033645 Pancreatitis Diseases 0.000 description 2
- 206010033647 Pancreatitis acute Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 201000003229 acute pancreatitis Diseases 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 238000006298 dechlorination reaction Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 239000002349 well water Substances 0.000 description 2
- 235000020681 well water Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- -1 hydroxyl free radical Chemical class 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000008400 supply water Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/469—Treatment of water, waste water, or sewage by electrochemical methods by electrochemical separation, e.g. by electro-osmosis, electrodialysis, electrophoresis
- C02F1/4693—Treatment of water, waste water, or sewage by electrochemical methods by electrochemical separation, e.g. by electro-osmosis, electrodialysis, electrophoresis electrodialysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1668—Details of containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1674—Apparatus for preparing dialysates using UV radiation sources for sterilising the dialysate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/4618—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/001—Processes for the treatment of water whereby the filtration technique is of importance
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/283—Treatment of water, waste water, or sewage by sorption using coal, charred products, or inorganic mixtures containing them
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/30—Treatment of water, waste water, or sewage by irradiation
- C02F1/32—Treatment of water, waste water, or sewage by irradiation with ultraviolet light
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
- C02F1/441—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis by reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/4618—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water
- C02F2001/4619—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water only cathodic or alkaline water, e.g. for reducing
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/4618—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water
- C02F2001/46195—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water characterised by the oxidation reduction potential [ORP]
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/02—Non-contaminated water, e.g. for industrial water supply
- C02F2103/026—Treating water for medical or cosmetic purposes
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/46—Apparatus for electrochemical processes
- C02F2201/461—Electrolysis apparatus
- C02F2201/46105—Details relating to the electrolytic devices
- C02F2201/4612—Controlling or monitoring
- C02F2201/46125—Electrical variables
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/04—Oxidation reduction potential [ORP]
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/06—Controlling or monitoring parameters in water treatment pH
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F9/00—Multistage treatment of water, waste water or sewage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/30—Hydrogen technology
- Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis
Abstract
本发明提供了一种对作为各种疾病的起因的活性氧具有消除能力的医疗用水、其制造方法及利用所述的医疗用水作为透析液的透析装置。上述医疗用水，其铂电极测定的氧化还原电位的实测值在-150mV～-0mV的范围内。将该水煮沸，即成为氧化还原电位的实测值在-68mV～+55mV范围内的杀菌的水。上述水在特殊条件下电解，在阴极一侧生成阴极水。所得的阴极水为含有丰富的电子(e-)、质子(H+)的水，具有可以消去发生于体内的活性氧的能力。
Description
技术领域
本发明涉及一种通常的医疗用水，更具体地说，涉及一种对体内发生的活性氧具有消除能力的医疗用水。本发明还涉及一种所述医疗用水的制造方法。本发明进一步涉及一种利用所述的水为透析液的透析装置。
背景技术
现代医学的进步令人吃惊，每年销售的新药的品种日益增多。另外，医疗器械的开发也在进行，使得医生可以更正确地把握患者的身体状态，可进行准确的治疗。再有，每年也有很多医科大学的毕业生进入社会，促进医疗技术灯的不断进步。
如上所述，现代医学在不断地进步。然而，随着上述的医学进步，本来，病人人数似应逐步有所减少，但是，事实上，病人的人数仍在不断增加，其所需的医疗费用也是日益增加。其原因大概可以认为是，人们往往是就疾病的症状进行对症疗法的治疗，而不是进行根本性的治疗。最近，在医疗领域，人们认识到，触发人类的各种疾病发生的起因为一种发生于人体内的活性氧(Superoxide Anion Radical：02-)。成为各种疾病的原因的该活性氧，可以认为是，溶入血液中的氧接受了缺血再灌、体内细菌、血液中的尿酸、中性脂肪、糖等的作用，被还原，或，由于中性白细胞的作用而被还原。
因此，在血液中的尿酸、中性脂肪、糖等较多的患者的血液中，或在患有疾病的患者的血液中，含有很多的活性氧。活性氧与体内的DNA等1起反应，发生如过敏性皮肤炎等的各种疾病。
目前，有关所述的血液中的活性氧的去除方法，全世界的医生及医疗机构都为之注目。
作为能够消去活性氧的代表性例子，迄今已有人举出如，β-胡萝卜素、维他命C、维生素E及SOD(过氧化物歧化酶)食品等。然而，上述食品等如摄取过多，则存在着氧化作用等的反作用，则也是一个问题。
为此，本发明的目的是，提供一种医疗用水，所述医疗用水对成为各种疾病发生的起因的活性氧具有消除能力。
本发明的其它目的是，提供一种所述的医疗用水的制造方法。
本发明的再一目的是，提供一种利用所述的医疗用水作为透析液的透析装置。
发明内容
按照本发明的第一个方面的医疗用水，其铂电极测定的氧化还原电位的实测值在-150mV--0mV的范围内。将该水煮沸，即成为氧化还原电位的实测值在-68mV-+55mV范围内的杀菌的水。
如上所述的水，在下述的特殊条件下，电解水而在阴极一侧生成(以下，简称为阴极水)。本发明者们发现，由改变其表现，所得的阴极水为含有丰富的电子(e-)、质子(H+)的水，具有可以消去发生于体内的活性氧的能力。
所述的阴极水，其消去活性氧的反应结构可认为如下：
O2 -(活性氧)+e-+2H+H2O2(过氧化氢)
H2O22HO·(羟基游离基)
HO·+e-+H+H2O
即，可称为各种疾病之源的活性氧，由阴极水中所含的电子
(e-)及质子(H+)的化合，被还原，变为H2O(水)，而被消去。
按照本发明的第二个方面的、医疗用水的制造方法中，首先，准备一个电解水生成器，该电解水生成器含有以隔膜分开的、内设阴极的阴极室和内设阳极的阳极室。将至少含有钠、钾、镁、钙离子的原水分别送入所述的阳极室及阴极室中。在上述阳极室及阴极室之间，对每二块电极和一块隔膜，通以0.16mA/cm2-3.2mA/cm2的范围内的电流，时间为0.5秒以上、5秒以下，电解上述的原水。其后，取出阴极室内的水。由此方法所得的阴极水，可以看到具有去除活性氧的能力。
按照本发明的第上方面的透析装置，所述装置具备下述的组成装置：
用于电解水的电解水生成装置；对从上述电解液储存罐送出的阴极水进行过滤的过滤装置；将由上述过滤装置导出的阴极水作为透析液供应的透析液供给装置。
按照本发明的第三个方面的透析装置，因该装置具有电解水生成装置，所以，可将除去了作为各种疾病的原因的活性氧的阴极水作为透析液供给至人体，因此，除了血液透析的效果之外，还可除去患者血液中的活性氧。
按照本发明的第四个方面的透析装置，所述装置具有用于电解水的电解水生成装置；使上述从所述的电解水生成装置送出的阴极水沸腾的煮沸装置；将由上述煮沸装置导出的阴极水作为透析液供应的透析液供给装置。
按照本发明的第四个方面的透析装置，因其具备煮沸装置，因此，可以杀死阴极水中含有的细菌。
附图的简单说明
图1为用于制造本发明的实施形态1有关的医疗用水的电解水生成器的示意图。
图2所示为使用一72岁的男性患者的血液，调查本发明的实施形态1有关的医疗用水的对于活性氧的消除能力的结果。
图3所示为使用一38岁的男性患者的血液，调查本发明的实施形态1有关的医疗用水的对于活性氧的消除能力的结果。
图4所示为使用一急性胰腺炎患者的血液，对本发明的水的效果所作的调查结果。
图5为用于说明本发明的实施形态2有关的透析装置的、以往的透析装置的示意图。
图6为本发明的实施形态2有关的透析装置的示意图。
图7为本发明的实施形态2的有关的透析装置的特征装置的详细图。
图8为本发明的实施形态3有关的透析装置的示意图。
图中，5为反渗透装置，9为透析液供给装置，a为电解水生成装置，b为电解水储存罐。
发明的实施形态
实施形态1
图1为本发明有关的制造医疗用水的电解水生成器的示意图。电解水生成器(HD-30)由内置阴极1的阴极水2和内置阳极3的阴极室4构成。阴极室2和阴极水4由隔膜5分离。阴极水2上连接有取出阴极液的阴极液取出管6，阴极室4上连接有将阳极水向外部排出的排水管7。阴极室2及阳极室4上，分别连接有给水管8，可以供给水道水、地下水、井水等的至少含有钠、钾、镁、钙的原水。
将水道水及地下水、井水等的原水送入阴极室1及阳极室4，在阴极1和阳极3之间，对每二块电极和一块隔膜，在室温下(18℃-22℃)通以0.16mA/cm2-3.2mA/cm2的范围内的电流，时间为0.5秒以上、5秒以下，电解原水，得到具有如下特性的、阴极水的医疗用水。另外，在本说明书中所述的氧化还原电位(ORP)为，用东亚电波株式会社制的ORP测量仪(RM-12P)，用铂电极所测得的实测值。
pH 8.0-9.5
ORP(氧化还原电位)：+0mV--150mV
下面，制得具有各种特性的阴极水，调查其在血液中的消去活性氧的能力。
图2所示为，将从一72岁的男性患者身上采取的血液和上述阴极水混合，该混合之后的血液中的活性氧的量的经时变化以图表显示。在图2中，横轴表示时间，纵轴表示活性氧的量。图中，在右纵轴上标为“control”的曲线是未加有上述阴极水的数据。在右纵轴上标记为1、2、3、4的曲线表示相对应于试验编号(PBS)的数据。
图3表示，从一38岁的男性患者身上采取血液，进行同样试验的结果。
从图2和图3可以看出，氧化还原电位(ORP)为-15mV-0mV的阴极水，其去除活性氧的能力很大。
图4为，使用并混合本发明的阴极水和采取自急性胰腺炎患者的血液，跟踪。显示活性氧的量的经时变化。计为Tap Water的直线表示将水道水和血液混合时的数据；计为Reduced Water的直线为将本发明的阴极水和血液混合时的结果。可以看到，用水道水时，活性氧的量并不减少，另一方面，用本发明的阴极水时，活性氧的量显著减少。
此外，水道水的pH为5.8-8.6，其氧化还原电位(ORP)为+200mV-700mV。
实施例1
下面，在各种电解电流(A)(通常，以电流密度(mA/cm2)表示)之下，急性电解(通电时间0.5-5秒)，此时，生成的水的PH和氧化还原电位(ORP)的值汇总于表1。通过这些试验，可以明白，电流密度较好地是0.16mA/cm2-3.2mA/cm2，特别好的是0.224mA/cm2-1.6mA/cm2。
其次，为了杀死如上所得的阴极水中所含的细菌，也作了煮沸阴极水的试验。其结果，可以看到，煮沸后的阴极水，并未失去消除活性氧的能力。
更详细地说明，则煮沸氧化还原电位为0mV及-150mV的二种电解水，维持煮沸状态5分钟，其后，冷却20分钟，测定其pH和ORP，结果示于表2及表3。
表2为使用高知市的水，在高知市进行测量的数据，表3为使用京都市的水，在京都市进行测量时的数据。可以明白，煮沸阴极水，则可得到其氧化还原实测值在-68mV-+55mV范围内的、杀菌了的医疗用水。
如上所得的阴极水(煮沸前及煮沸后)，可稳定80小时以上，如加以密封，则可保存一年而无特性的劣化。
发明的实施形态2
本发明的实施形态也涉及一种可将加以上述特性的阴极水用作透析液的、改进的透析装置。
在说明本发明的装置之前，先就已有的透析装置作一说明。
图5为已有的透析装置的示意图。穿照图5，使水道水(原水)通过沉淀过滤器1，除去尘杂；在软化装置2，对水进行软化；由活性炭过滤装置3，除去氯、氯胺和毒素；通过UV(紫外线)杀菌灯4，送入反渗透装置5。反渗透装置5上，送入加压后的水，但是，透过该装置的仅约二分之一，其余的作为排水处理掉了。上述透过的水为无菌的纯水，其后，蓄于RO水槽6，再以UV杀菌灯7杀菌，通过微孔过滤器8，送入透析液供给装置9。在这里，处理过的水以碳酸氢钠原液和电解原液的所定的比率被混合，通过脱气装置，作为透析液改进于人体。
所谓由透析装置所进行的血液透析，即指，将作体内循环的患者的血液和透析液(电解质液之一种)，在称为人工肾透析机的透析器上，通过一薄膜而进行物质交换的治疗方法，该方法可除去血液中的溶质并去除供给和多余的水分。慢性肾功能不全的患者，通常，每周接受3次，每次4小时左右的血液透析。供给透析器的透析液的流量通常为500ml/分，因此，一次治疗所用的透析液的用量可达每人500ml×240分＝12万ml-1201(升)。这样，所谓血液透析，即是由大量的水进行的治疗，对于患者来说，使用于血液透析的水的影响是很大的。本发明的实施形态即着眼于该目的，系有关将上述的、加压特定组成的阴极水用于透析装置。
图6为本发明的实施形态2有关的透析装置的示意图。
本发明的实施形态2有关的透析装置，与图5所示的已有的透析装置的不同之处是，该装置系在UV杀菌灯、反渗透装置5之间，组入电解水生成装置a和电解水储存罐b。
使水道水(原水)通过沉淀过滤器1，除去尘杂；在软化装置2，对水进行软化；由活性炭过滤装置3，除去氯、氯胺和毒素；通过UV(紫外线)杀菌灯4，再将通过上述处理的水送入电解水生成装置a，进行电解。电解后所得的阴极水储存于存储罐b，送入反渗透装置5。反渗透装置5上，此时，透过该装置的水仅占送入水的约二分之一，其余未通过的装置，经过设于反渗透装置5和电解水储存罐b之间的、回水用的管道11，由泵11，返回至RO水槽6。上述透过反渗透装置的水几近为无菌的纯水，其后，蓄于RO水槽6，再通过UV杀菌灯7杀菌，通过微孔过滤器8，送入透析液供给装置9。在这里，处理过的水以碳酸氢钠原液和电解原液的所定的比率被混合，通过脱气装置，作为透析液供给于人体10。
图7为将图6中所示的活性炭过滤装置3、电解水生成装置(HD-30)a、电解水储存罐b及反渗透装置5的装置取出，再作详细的图示。
在本发明的实施形态中，例示了设有四个电解水生成器(HD-30)的情况，但，本发明并不限于此例。
又，在上述本发明的实施形态中，例示了设有电解液储存罐的情况，但是，本发明也并不限于此，电解液储存罐并不是必要的，也可直接从电解水生成装置a将水供给至反渗透装置5。
另外，在所示的本发明的实施形态中，作为用于过滤阴极水的装置，例示了反渗透过滤装置，但，本发明并不限于此，也可采用中空丝膜过滤装置。
使用本发明的实施形态2有关的透析装置，则除了可获得已有的血液渗透的效果之外，也可除去患者血液中的活性氧。其结果，对于慢性肾功能不全患者，透析频度减轻，且，透析时间缩短，由此，可不受透析装置的约束，减少时间。
发明的实施形态3
图8为本发明的实施形态3有关的透析装置的示意图。图8所示的透析装置，除了以下几点不同之外，其余皆和图6所示的透析装置相同，因此，同一、或相同的装置标以同样的符号，不再重复说明。
图8所示的透析装置与图6所示的透析装置的不同之处如下。即，本发明的实施形态3有关的透析装置，不具备UV杀菌灯、反渗透装置、RO水槽、微孔过滤装置等的杀菌设施，二具有煮沸设施的锅炉12。从电解水b移送至锅炉12的水经煮沸、杀菌后，送入透析液供给装置9，用于患者10。这样，以锅炉12取代杀菌设施，比起使用UV杀菌灯等的杀菌方法来，其成本及维修都有有利之处。
另外，上述本发明的实施形态1-3中，都例示了将具有上述特性的医疗用水用作清洗血液用的例子，但是，本发明并不限于这些，本发明的医疗用水也可用于林格液、手术用等的洗净水等。
Claims (9)
1.一种医疗用水电解水的制备方法，其特征在于，所述电解水以铂电极所测得氧化还原电位的实测值在-150mV-0mV的范围，所述方法包括：
准备一个电解水处理装置，所述电解水处理装置含有以隔膜分开的、内设阴极的阴极室和内设阳极的阳极室；
将至少含有钠、钾、镁、钙离子的原水分别送入所述阳极室及阴极室中；
在上述阳极及阴极之间，对每二块电极和一块隔膜，通以0.16mA/cm2-3.2mA/cm2的范围内的电流达0.5秒-5秒，电解上述原水；
其后，取出上述阴极室内的电解水。
2.如权利要求1所述的医疗用电解水制备方法，其特征在于，所述电流在0.224mA-1.6mA/cm2范围。
3.如权利要求1所述的医疗用电解水制备方法，其特征在于，所述方法进一步包括将所述取出的水煮沸的工序。
4.一种用权利要求1所述方法制备的医疗用电解水，制造透极液的透析装置，其特征在于，所述装置包括：
将水电解的电解水处理装置；
过滤由上述电解水处理装置送出的阴极水的过滤装置；
将由上述过滤装置导出的阴极水作为透析液供给的透析液供给装置；
藉由所述透析液，用于患者体内循环血液的透析的透析设备。
5.如权利要求4所述的透析装置，其特征在于，上述电解水处理装置供给电解水，所述电解水以铂电极所测得氧化还原电位的实测值在-150mV-0mV的范围。
6.如权利要求4所述的透析装置，其特征在于，所述的透析装置包括设置于上述的过滤装置，将从上述电解水生成装置过量送入的所述阴极水排出的排出装置。
7.如权利要求6所述的透析装置，其特征在于，所述的排水装置含有：
设置于所述的电解水生成装置和所述的过滤装置之间、将从上述过滤装置过量地送入的所述阴极水返回至上述电解水生成装置的回水管道，和
设置于上述回水管道内的泵。
8.一种透析装置，其特征在于，所述透析装置包括：
具有用于将水电解的电解水处理装置；
使上述从所述的电解水处理装置送出的阴极水沸腾的煮沸装置；
将由上述煮沸装置导出的阴极水作为透析液供应的透析液供给装置；
藉由所述透析液，用于患者体内循环血液的透析的透析设备。
9.如权利要求8所述的透析装置，其特征在于，所述电解水处理装置供给电解水，所述电解水以铂电极所测得氧化还原电位的实测值在-150mV-0mV的范围。
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP171902/95 | 1995-07-07 | ||
| JP17190295 | 1995-07-07 | ||
| JP171902/1995 | 1995-07-07 | ||
| JP155647/96 | 1996-06-17 | ||
| JP155647/1996 | 1996-06-17 | ||
| JP15564796A JP3193295B2 (ja) | 1995-07-07 | 1996-06-17 | 透析装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1144193A CN1144193A (zh) | 1997-03-05 |
| CN1119291C true CN1119291C (zh) | 2003-08-27 |
Family
ID=26483587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96108522A Expired - Lifetime CN1119291C (zh) | 1995-07-07 | 1996-07-05 | 医疗用电解水的制造方法及利用该水作透析液的透析装置 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5938915A (zh) |
| EP (1) | EP0752391B1 (zh) |
| JP (2) | JP3193295B2 (zh) |
| CN (1) | CN1119291C (zh) |
| CA (1) | CA2180487C (zh) |
| DE (1) | DE69631857T2 (zh) |
| RU (1) | RU2120413C1 (zh) |
| TW (1) | TW505519B (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104114495A (zh) * | 2012-07-06 | 2014-10-22 | 日本多宁股份有限公司 | 用来生产用于制备透析液的水的设备 |
| CN108473344A (zh) * | 2016-02-02 | 2018-08-31 | 日本多宁股份有限公司 | 电解水生成装置和使用其的透析液制备用水的制造装置及电解水生成方法 |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69821973T2 (de) * | 1997-12-04 | 2004-11-11 | Steris Corp., Mentor | Chemische änderung von elektrochemisch aktiviertem wasser |
| GB2332210B (en) * | 1997-12-10 | 2000-07-19 | Toshiba Kk | Processing method of waste water and processing apparatus thereof |
| US6231874B1 (en) * | 1998-03-13 | 2001-05-15 | Color Access, Inc. | Structured water for enhanced moisturization |
| US6139855A (en) * | 1998-03-13 | 2000-10-31 | Color Access, Inc. | Structured water in cosmetic compositions |
| DE29809867U1 (de) * | 1998-06-04 | 1998-09-24 | Buettner Klaus | UV-Strahler für die Haemodialyse |
| JP5275532B2 (ja) * | 1999-02-26 | 2013-08-28 | 池田物産株式会社 | 製剤組成物 |
| TW546257B (en) | 1999-09-01 | 2003-08-11 | Nihon Trim Co Ltd | Method and apparatus for producing electrolytic reduced water |
| JP3432778B2 (ja) | 1999-11-19 | 2003-08-04 | 森澤 紳勝 | 活性酸素消去剤の濃縮液、その製造方法および活性酸素消去剤パウダー |
| US7090878B2 (en) * | 2001-05-31 | 2006-08-15 | The Procter & Gamble Company | Mineral fortified water |
| JP5140218B2 (ja) | 2001-09-14 | 2013-02-06 | 有限会社コヒーレントテクノロジー | 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法 |
| JP3988827B2 (ja) | 2001-12-05 | 2007-10-10 | オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド | 負および正の酸化還元電位（ｏｒｐ）水を生成するための方法および装置 |
| EP1607005B1 (en) * | 2001-12-11 | 2008-10-08 | Xiao Bing Wang | The effect of a buffering agent on acidogenesis of plaque |
| TWI231182B (en) * | 2001-12-11 | 2005-04-21 | Shinkatsu Morisawa | The effect of a buffering agent on acidogenesis of plaque |
| CN1298309C (zh) * | 2001-12-11 | 2007-02-07 | 王小兵 | 缓冲剂对牙菌斑酸化的作用 |
| US9168318B2 (en) | 2003-12-30 | 2015-10-27 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and methods of using the same |
| EP1614437B1 (en) * | 2004-07-08 | 2010-03-31 | Peter Taboada, S.l. | Water treatment system for haemodialysis |
| US8323252B2 (en) | 2005-03-23 | 2012-12-04 | Oculus Innovative Sciences, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
| EP1896043B1 (en) | 2005-05-02 | 2018-08-29 | Sonoma Pharmaceuticals, Inc. | Method of using oxidative reductive potential water solution in dental applications |
| US20060266381A1 (en) * | 2005-05-27 | 2006-11-30 | Doherty James E | Commercial glassware dishwasher and related method |
| DE102005049951B4 (de) * | 2005-10-19 | 2015-05-13 | Franz Ferdinand Becker | Apparatur zur Herstellung von physiologischen, therapeutischen und chemotherapeutischen wässrigen Spüllösungen |
| US20070272619A1 (en) * | 2006-01-20 | 2007-11-29 | Pavol Banacky | Production of distinct water fractions |
| US20070196434A1 (en) | 2006-01-20 | 2007-08-23 | Oculus Innovative Sciences, Inc. | Methods of preventing or treating sinusitis with oxidative reductive potential water solution |
| JP4004523B1 (ja) * | 2006-04-21 | 2007-11-07 | 株式会社日本トリム | 透析液調製用水およびそれを用いた透析液、透析液の製造方法ならびに透析装置 |
| KR100785017B1 (ko) * | 2006-06-05 | 2007-12-12 | 삼성전자주식회사 | 혈액으로부터 핵산을 증폭하는 방법 |
| MY163799A (en) * | 2008-02-07 | 2017-10-24 | Dsg Tech Holdings Limited | Method of making an absorbent composite and absorbent articles employing the same |
| US9101537B2 (en) | 2008-07-25 | 2015-08-11 | Reven Pharmaceuticals, Inc. | Compositions and methods for the prevention and treatment of cardiovascular diseases |
| JPWO2010026764A1 (ja) * | 2008-09-03 | 2012-02-02 | Ｃａｍｂｗｉｃｋ Ｈｅａｌｔｈｃａｒｅ株式会社 | 電子照射生理的等張液及び電子照射生理的等張液製造用の電子照射装置、臓器保存容器 |
| JP2010063629A (ja) * | 2008-09-10 | 2010-03-25 | Nippon Torimu:Kk | 透析装置 |
| JP6033082B2 (ja) | 2009-06-15 | 2016-11-30 | オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド | 次亜塩素酸を含有する溶液及びその使用方法 |
| US10266441B2 (en) * | 2010-05-19 | 2019-04-23 | Coway Co., Ltd | Water treatment apparatus and sterilizing and cleansing method thereof |
| CA2806208C (en) | 2010-07-22 | 2018-02-13 | Zishan Haroon | Methods of treating or ameliorating diseases and enhancing performance comprising the use of a magnetic dipole stabilized solution |
| EP2450313A1 (de) * | 2010-11-09 | 2012-05-09 | Caliopa AG | Verfahren zur Erzeugung einer elektrochemisch aktvierten Lösung durch Elektrolyse |
| JP5872321B2 (ja) * | 2012-02-24 | 2016-03-01 | 柴田 猛 | 透析液・原液水素還元装置 |
| JP6017911B2 (ja) * | 2012-06-15 | 2016-11-02 | 株式会社日本トリム | 個人透析用の人工透析用水製造装置 |
| JP6183832B2 (ja) * | 2013-06-19 | 2017-08-23 | 扶桑薬品工業株式会社 | 酸化ストレス抑制型透析用剤およびその調製方法 |
| JP5901665B2 (ja) * | 2014-01-27 | 2016-04-13 | 株式会社日本トリム | 透析液調製用水の製造装置 |
| JP6400918B2 (ja) * | 2014-02-18 | 2018-10-03 | オルガノ株式会社 | 水素溶解水製造装置及び純水製造システム |
| CN205550627U (zh) * | 2015-09-20 | 2016-09-07 | 大连双迪创新科技研究院有限公司 | 淋浴莲蓬头 |
| EP3536824B1 (en) | 2016-11-04 | 2021-04-21 | Nihon Trim Co., Ltd. | Solid polymer film electrode |
| GB201619493D0 (en) * | 2016-11-17 | 2017-01-04 | Garcia Vicente | Portable water dispenser having a pressure booster faucet for pushing water through an ionizing device |
| JP6853048B2 (ja) * | 2017-01-18 | 2021-03-31 | 株式会社日本トリム | 電解水生成装置及び透析液調製用水の製造装置 |
| DE102018000121B4 (de) * | 2018-01-09 | 2020-01-30 | Daniel Hill | Digitalisiertes Wasseraufbereitungsgerät durch Elektrolyse mit integrierter Herzratenvariabilitäts- und Pulswellenvolumenanalysefuntion für den Anwender |
| JP7324904B1 (ja) * | 2022-06-10 | 2023-08-10 | 株式会社日本トリム | 水処理装置 |
| JP7181436B1 (ja) | 2022-07-19 | 2022-11-30 | 株式会社神戸製鋼所 | ロボットの制御方法、およびロボットの制御装置 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1512146A (en) * | 1975-10-06 | 1978-05-24 | Sachs Systemtechnik Gmbh | Electrolytic water-purifying apparatus |
| SE403438B (sv) * | 1976-02-26 | 1978-08-21 | Gambro Ab | Anordning for behandling av blod eller liknande omtaliga vetskor |
| DE3174243D1 (en) * | 1981-07-17 | 1986-05-07 | Arbeitsgruppe Tech Photosynthe | Process and arrangement for carrying out the process for the photochemical cleavage of water and reduction of nitrogen from the atmosphere using a structure of molecular dimensions |
| DE3641843A1 (de) * | 1986-12-08 | 1988-06-16 | Fresenius Ag | Haemodialysevorrichtung mit sterilisiereinrichtung |
| SU1752315A1 (ru) * | 1987-03-05 | 1992-08-07 | Специализированное Монтажно-Наладочное Управление Государственного Комитета Узсср По Промышленному Птицеводству | Способ содержани сельскохоз йственной птицы |
| CA1319849C (en) * | 1987-09-25 | 1993-07-06 | Ernst Graf | Oxygen removal |
| US4808287A (en) * | 1987-12-21 | 1989-02-28 | Hark Ernst F | Water purification process |
| JPH06193971A (ja) * | 1992-12-24 | 1994-07-15 | Mitsubishi Electric Corp | 電解水生成機能付電気温水器 |
| EP0605882B1 (en) * | 1993-01-08 | 1996-12-11 | Nec Corporation | Method and apparatus for wet treatment of solid surfaces |
| ES2115156T3 (es) * | 1993-02-22 | 1998-06-16 | Nippon Intek Co Ltd | Procedimiento y dispositivo para producir agua electrolitica. |
| HU216042B (hu) * | 1993-07-14 | 1999-04-28 | B. Braun Medical Kft. | Berendezés szerves anyaggal szennyezett folyadék, előnyösen dializálófolyadék regenerálására, valamint eljárás és jeladó szerves anyag és hipoklorition kombinált méréséhez |
| JPH0788475A (ja) * | 1993-09-24 | 1995-04-04 | Matsuo Seitai Butsuri Kenkyusho:Kk | 塩基性電解生成水 |
| JPH07185550A (ja) * | 1993-12-28 | 1995-07-25 | Matsuo Seitai Butsuri Kenkyusho:Kk | 電解生成水 |
| JP2830733B2 (ja) * | 1994-03-25 | 1998-12-02 | 日本電気株式会社 | 電解水生成方法および電解水生成機構 |
-
1996
- 1996-06-17 JP JP15564796A patent/JP3193295B2/ja not_active Expired - Lifetime
- 1996-06-25 TW TW085107609A patent/TW505519B/zh not_active IP Right Cessation
- 1996-07-03 US US08/675,660 patent/US5938915A/en not_active Expired - Lifetime
- 1996-07-04 CA CA002180487A patent/CA2180487C/en not_active Expired - Lifetime
- 1996-07-05 CN CN96108522A patent/CN1119291C/zh not_active Expired - Lifetime
- 1996-07-05 EP EP96304974A patent/EP0752391B1/en not_active Expired - Lifetime
- 1996-07-05 RU RU96115403A patent/RU2120413C1/ru active
- 1996-07-05 DE DE69631857T patent/DE69631857T2/de not_active Expired - Lifetime
-
2000
- 2000-04-05 JP JP2000103512A patent/JP3436912B2/ja not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104114495A (zh) * | 2012-07-06 | 2014-10-22 | 日本多宁股份有限公司 | 用来生产用于制备透析液的水的设备 |
| CN108473344A (zh) * | 2016-02-02 | 2018-08-31 | 日本多宁股份有限公司 | 电解水生成装置和使用其的透析液制备用水的制造装置及电解水生成方法 |
| CN108473344B (zh) * | 2016-02-02 | 2022-03-29 | 日本多宁股份有限公司 | 电解水生成装置和使用其的透析液制备用水的制造装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0752391A3 (en) | 1997-11-12 |
| TW505519B (en) | 2002-10-11 |
| CA2180487C (en) | 2001-04-10 |
| EP0752391A2 (en) | 1997-01-08 |
| JP2000350989A (ja) | 2000-12-19 |
| JP3436912B2 (ja) | 2003-08-18 |
| DE69631857D1 (de) | 2004-04-22 |
| JP3193295B2 (ja) | 2001-07-30 |
| CA2180487A1 (en) | 1997-01-08 |
| EP0752391B1 (en) | 2004-03-17 |
| RU2120413C1 (ru) | 1998-10-20 |
| US5938915A (en) | 1999-08-17 |
| DE69631857T2 (de) | 2005-03-17 |
| CN1144193A (zh) | 1997-03-05 |
| JPH0977672A (ja) | 1997-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1119291C (zh) | 医疗用电解水的制造方法及利用该水作透析液的透析装置 | |
| CA2212763C (en) | Electrolytic hydrogen dissolved water, and method and apparatus for production thereof | |
| WO2014006740A1 (ja) | 透析液調製用水の製造装置 | |
| JP5714060B2 (ja) | 透析液調製用水の製造装置 | |
| JP5940689B1 (ja) | 透析液調製用水の製造装置 | |
| JP2014161605A (ja) | 水素付加装置および腹膜透析装置 | |
| JP5840248B2 (ja) | 透析液の製造装置 | |
| JP5028397B2 (ja) | 医療用精製水の製造方法 | |
| JP2015177911A (ja) | 透析液の製造装置 | |
| JP2016101565A (ja) | 水素水の製造方法および水素水製造装置 | |
| TWI746833B (zh) | 血液透析用透析液 | |
| TWI728115B (zh) | 透析液製造裝置的清洗方法 | |
| JP4332829B2 (ja) | 透析システム | |
| CA2406476C (en) | Water for medical treatment, production method thereof, and dialysis apparatus using water for medical treatment as dialysis liquid | |
| JP2005281238A (ja) | 海水を利用した医療用電解質液およびその製造方法 | |
| US20240016832A1 (en) | Dialysate for hemodialysis | |
| CA2303676C (en) | Water for medical treatment, production method thereof, and dialysis apparatus using water for medical treatment as dialysis liquid | |
| JP2000024104A (ja) | 血液処理用膜とその製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20030827 |
|
| EXPY | Termination of patent right or utility model |